Seven things to know:
1. As of July 30, CDC has received reports of 4,404 U.S. children who have been diagnosed with COVID-19-associated MIS-C.
2. As of July 30, 37 total MIS-C deaths have been reported.
3. The median age of MIS-C patients was 9 years.
4. Sixty three percent of the reported patients with race/ethnicity information available occurred in children who are Hispanic or Latino or Black.
5. Most (99 percent) of patients had a positive COVID-19 test result. The remaining 1 percent had contact with someone with COVID-19.
6. Sixty percent of reported patients were male.
7. CDC is working to learn more about why some children and adolescents develop MIS-C after having COVID-19 or contact with someone with COVID-19, while others do not.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
